Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma
巴雷特食管进展为食管腺癌的早期目标
基本信息
- 批准号:9277831
- 负责人:
- 金额:$ 108.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-21 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdenocarcinomaAdvisory CommitteesAppearanceBarrett EsophagusBindingBiochemistryBudgetsCandidate Disease GeneCell surfaceCellsCenter for Translational Science ActivitiesClinicalClinical DataClinical ResearchCommunicationContractsDNADNA Sequence AlterationDNA copy numberDana-Farber Cancer InstituteDataDatabasesDetectionDeveloped CountriesDeveloping CountriesDimerizationDiseaseEndoscopesEndoscopyEsophagealEsophageal AdenocarcinomaEsophagogastric JunctionEsophagusExcisionFiberFormalinFoundationsFreezingGene ExpressionGene Expression ProfilingGene TargetingGenesGenomicsGoalsGrantHumanImageImmunohistochemistryIncidenceIndividualInstitutionInvestigational New Drug ApplicationLabelLesionLigandsLightLongitudinal cohortMalignant NeoplasmsMalignant neoplasm of esophagusMedicalMethodologyMichiganMissionMolecular ProfilingMolecular TargetMutationNeoplasmsOperative Surgical ProceduresOutcomeParaffin EmbeddingPatient RecruitmentsPatientsPeptidesPerformancePharmacology and ToxicologyPilot ProjectsPlasmaPremalignantPreventive measureProcessProtocols documentationResearchResearch PersonnelResearch Project GrantsResourcesReverse Transcriptase Polymerase Chain ReactionRiskRisk stratificationScreening for cancerSensitivity and SpecificitySerumSpatial DistributionSpecimenSurvival RateTelomeraseTestingTherapeutic InterventionTimeTissue MicroarrayTissuesTranslational ResearchUniversitiesUpdateVariantWashingtonbiobankclinical translationcohortdimerflexibilitygastroesophageal junction adenocarcinomagenomic toolshuman subjectimaging agentimaging modalityimprovedin vivoinnovationmonomernoveloverexpressionpatient registryprogramssample collectionspectrographsynergismtranscriptome sequencingtumor heterogeneityvirtual
项目摘要
- Project Summary/Abstract
Recently, the incidence of esophageal (EAC) and gastro-esophageal junction (GEJAC) adenocarcinoma
has increased dramatically, and have a poor 5-year survival rate of less than 15%. When detected early, these
patients can have a good clinical outcome following surgery. These observations underscore the importance
of early cancer detection. Patients with Barrett's esophagus (BE) are known to be at increased risk.
Our overarching goal is to advance new methods of imaging to visualize the effects of spatial distribution
of genetic alterations in BE by using novel imaging methods to evaluate tumor heterogeneity on the
progression toward EAC. We propose a multi-institutional, trans-disciplinary, translational Research Center in
the Barrett's Esophagus Translational Research Network (BETRNet). Our mission is to build on our expertise
in genomic characterization, peptide biochemistry, and clinical translation to achieve our ultimate goal to
perform early cancer detection at an early stage where therapeutic intervention can be most effective. We will
identify a complementary panel of genes that are overexpressed on the cell surface and will be used to
develop and validate new peptide imaging agents. The targets chosen will address 3 important clinical needs:
1) Real-time endoscopic identification of pre-malignant lesions and early stage cancer to guide endoscopic
resection; 2) Risk stratification of BE patients for timing of endoscopic surveillance; and 3) Detection of gastro-
esophageal junction adenocarcinomas in patients without endoscopic appearance of BE.
We will use state-of-the-art genomic tools to to identify early overexpressed gene targets that arise in
progression of BE to EAC by providing comprehensive analyses of gene expression alterations, DNA copy
number variation, and genetic mutations. We will select candidate genes that are expressed on the cell
surface where they can be endoscopically imaged in vivo. We will rigorously validate the panel of candidate
targets with quantitative RT-PCR and immunohistochemistry on tissue microarrays using an independent
cohort of human esophagus specimens. We will use these targets to first identify and validate monomer
peptides that are highly specific. We will then arrange monomer peptides in a dimer configuration to produce
multivalent ligand target interactions to improve binding performance and allow for early targets to be detected
at low levels of expression. We will use a flexible fiber multi-spectral endoscope that can pass through the
working channel of a standard medical endoscope to detect multiple targets at the same time.
Successful completion of these aims will provide an integrated multi-spectral imaging methodology to
longitudinally visualize overexpressed molecular targets that drive progression of Barrett's esophagus to
esophageal adenocarcinoma. This innovative approach can serve as the foundation for validated preventive
measures to improve patient management.
-项目摘要/摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID George BEER其他文献
DAVID George BEER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID George BEER', 18)}}的其他基金
RNF128 Regulation of TP53 in Barrett's Progression
RNF128 对 Barrett 进展中 TP53 的调节
- 批准号:
10219176 - 财政年份:2017
- 资助金额:
$ 108.42万 - 项目类别:
Biomedical Computing and Informatics Strategies for Precision Medicine
精准医学的生物医学计算和信息学策略
- 批准号:
9366045 - 财政年份:2017
- 资助金额:
$ 108.42万 - 项目类别:
RNF128 Regulation of TP53 in Barrett's Progression
RNF128 对 Barrett 进展中 TP53 的调节
- 批准号:
9976469 - 财政年份:2017
- 资助金额:
$ 108.42万 - 项目类别:
Multi-Spectral Targeted Imaging for Early Detection of Cancer in Barrett's Esopha
多光谱靶向成像用于巴雷特食管癌症的早期检测
- 批准号:
8724430 - 财政年份:2011
- 资助金额:
$ 108.42万 - 项目类别:
Identification and Characterization of Gene Fusions in Lung Adenocarcinoma
肺腺癌基因融合的鉴定和表征
- 批准号:
8018735 - 财政年份:2011
- 资助金额:
$ 108.42万 - 项目类别:
Identification and Characterization of Gene Fusions in Lung Adenocarcinoma
肺腺癌基因融合的鉴定和表征
- 批准号:
8249361 - 财政年份:2011
- 资助金额:
$ 108.42万 - 项目类别:
Multi-Spectral Targeted Imaging for Early Detection of Cancer in Barrett's Esopha
多光谱靶向成像用于巴雷特食管癌症的早期检测
- 批准号:
8919278 - 财政年份:2011
- 资助金额:
$ 108.42万 - 项目类别:
Project 1: Identification and Validation of Panel of Early Cell Surface Gene Targets
项目 1:早期细胞表面基因靶标组的鉴定和验证
- 批准号:
10155438 - 财政年份:2011
- 资助金额:
$ 108.42万 - 项目类别:
Multi-Spectral Targeted Imaging for Early Detection of Cancer in Barrett's Esopha
多光谱靶向成像用于巴雷特食管癌症的早期检测
- 批准号:
8209767 - 财政年份:2011
- 资助金额:
$ 108.42万 - 项目类别:
Identification of Cell Surface Targets Based on Gene Amplification/Overexpression
基于基因扩增/过表达的细胞表面靶点鉴定
- 批准号:
8244086 - 财政年份:2011
- 资助金额:
$ 108.42万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 108.42万 - 项目类别:
Research Grant